Atypical teratoid/rhabdoid tumour

Changed by Yahya Baba, 26 Oct 2022
Disclosures - updated 6 Apr 2022: Nothing to disclose

Updates to Article Attributes

Body was changed:

Atypical teratoid/rhabdoid tumours (AT/RT) are uncommon WHO grade 4 tumours, which in the vast majority of cases occurs in young children less than two years of age. It most frequently presents as a posterior fossa mass. AT/RT often resembles medulloblastoma by imaging and even H&E microscopy, and the diagnosis requires cytogenetic analysis of the tissue.

Epidemiology

AT/RTs typically present in very young children (median age is less than 2-3 years 2,13).

Pathology

Microscopic features

Rhabdoid cells are the hallmark of AT/RT, but only comprise a fraction of the tumour and are not required for the diagnosis provided genetic of DNA-methylation changes are compatible (see below) 13.

Other portions of the tumour are indistinguishable on imaging and histology from a medulloblastoma or embryonal tumour with multilayered rosettes.

Genetics

The vast majority (~95%) of AT/RTs have inactivation of both copies of SMARCB1 (also known as INI1, BAF47 or hSNF5). In a small minority of cases (< 5%) it is SMARCA4 (also known as BRG1) that is inactivated 13

Additionally, AT/RTs can be divided into three subgroups according to DNA-methylation profiling: AT/RT-SHH, AT/RT-TYR, and AT/RT-MYC 13.

To make the diagnosis, either SMARCB1 or SMARCA4 mutations or compatible DNA-methylation profiling need to identified 13

Immunophenotype

Rhabdoid cells usually demonstrate:

  • EMA: positive
  • vimentin: positive
  • SMA (smooth muscle actin): positive

Radiographic features

Atypical teratoid/rhabdoid tumours are usually large and very heterogeneous masses. They may be difficult to distinguish from an embryonal tumour with multilayered rosettes by imaging.

Location
  • infratentorial: ~50%
    • cerebellum (most common)
    • brainstem
  • supratentorial
CT
  • often isodense to grey matter
  • may demonstrate heterogeneous enhancement
  • calcification is common
  • may show associated obstructive hydrocephalus
MRI

Can show necrosis, multiple foci of cyst formation and sometimes haemorrhage:

  • T1: iso- to slightly hyperintense to grey matter (haemorrhagic areas can be more hyperintense)
  • T2: generally hyperintense (haemorrhagic areas can be hypointense)
  • T1 C+ (Gd): heterogeneous enhancement
  • MR spectroscopy
    • Cho: elevated
    • NAA: decreased
  • DWI
    • almost all restrict diffusion

Leptomeningeal seeding has been described in up to 15-30% of cases and so post-contrast imaging of the entire neuroaxis should be considered in suspected AT/RTs.

Treatment and prognosis

Surgery with debulking can be offered in some cases. Tumours can demonstrate leptomeningeal dissemination. Clinically AT/RTs have a much poorer prognosis than medulloblastomas, with little if any response to chemotherapy and death usually occurring within a year of diagnosis. 

History and etymology

Primary CNS rhabdoid tumour was first identified as a unique entity in the mid/late 1980s. Prior to this, these tumours were likely misdiagnosed as primitive neuroectodermal tumour/medulloblastoma, as they are relatively similar in microscopic appearance 12. Early reports variably used the term malignant rhabdoid tumour.

Differential diagnosis

Imaging differential considerations include:

  • -<p><strong>Atypical teratoid/rhabdoid tumours</strong> <strong>(AT/RT)</strong> are uncommon <a href="/articles/who-classification-of-cns-tumours-1">WHO grade 4</a> tumours, which in the vast majority of cases occurs in young children less than two years of age. It most frequently presents as a <a href="/articles/posterior-fossa-tumours">posterior fossa mass</a>. AT/RT often resembles <a href="/articles/medulloblastoma">medulloblastoma</a> by imaging and even H&amp;E microscopy, and the diagnosis requires cytogenetic analysis of the tissue.</p><h4>Epidemiology</h4><p>AT/RTs typically present in very young children (median age is less than 2-3 years <sup>2,13</sup>).</p><h4>Pathology</h4><h5>Microscopic features</h5><p>Rhabdoid cells are the hallmark of AT/RT, but only comprise a fraction of the tumour and are not required for the diagnosis provided genetic of DNA-methylation changes are compatible (see below) <sup>13</sup>.</p><p>Other portions of the tumour are indistinguishable on imaging and histology from a medulloblastoma or <a href="/articles/embryonal-tumour-with-multilayered-rosettes">embryonal tumour with multilayered rosettes</a>.</p><h5>Genetics</h5><p>The vast majority (~95%) of AT/RTs have inactivation of both copies of SMARCB1 (also known as INI1, BAF47 or hSNF5). In a small minority of cases (&lt; 5%) it is SMARCA4 (also known as BRG1) that is inactivated <sup>13</sup>. </p><p>Additionally, AT/RTs can be divided into three subgroups according to <a href="/articles/dna-methylation">DNA-methylation profiling</a>: AT/RT-SHH, AT/RT-TYR, and AT/RT-MYC <sup>13</sup>.</p><p>To make the diagnosis, either SMARCB1 or SMARCA4 mutations or compatible DNA-methylation profiling need to identified <sup>13</sup>. </p><h5>Immunophenotype</h5><p>Rhabdoid cells usually demonstrate:</p><ul>
  • -<li>
  • -<a href="/articles/epithelial-membrane-antigen-ema">EMA</a>: positive</li>
  • -<li>
  • -<a href="/articles/vimentin">vimentin</a>: positive</li>
  • -<li>
  • -<a href="/articles/smooth-muscle-actin">SMA</a> (smooth muscle actin): positive</li>
  • -</ul><h4>Radiographic features</h4><p>Atypical teratoid/rhabdoid tumours are usually large and very heterogeneous masses. They may be difficult to distinguish from an embryonal tumour with multilayered rosettes by imaging.</p><h5>Location</h5><ul>
  • -<li>infratentorial: ~50%<ul>
  • -<li>cerebellum (most common)</li>
  • -<li>brainstem</li>
  • -</ul>
  • -</li>
  • -<li>supratentorial<ul>
  • -<li>cerebral hemispheres</li>
  • -<li>pineal gland region (see <a href="/articles/pineal-region-mass">pineal mass differential diagnosis</a>)</li>
  • -<li>septum pellucidum</li>
  • -<li>hypothalamus</li>
  • -</ul>
  • -</li>
  • -</ul><h5>CT</h5><ul>
  • -<li>often isodense to grey matter</li>
  • -<li>may demonstrate heterogeneous enhancement</li>
  • -<li>calcification is common</li>
  • -<li>may show associated <a href="/articles/obstructive-hydrocephalus">obstructive hydrocephalus</a>
  • -</li>
  • -</ul><h5>MRI</h5><p>Can show necrosis, multiple foci of cyst formation and sometimes haemorrhage:</p><ul>
  • -<li>
  • -<strong>T1:</strong> iso- to slightly hyperintense to grey matter (haemorrhagic areas can be more hyperintense)</li>
  • -<li>
  • -<strong>T2:</strong> generally hyperintense (haemorrhagic areas can be hypointense)</li>
  • -<li>
  • -<strong>T1 C+ (Gd):</strong> heterogeneous enhancement</li>
  • -<li>
  • -<strong>MR spectroscopy</strong><ul>
  • -<li>
  • -<a href="/articles/choline-peak">Cho</a>: elevated</li>
  • -<li>
  • -<a href="/articles/n-acetylaspartate-naa-peak">NAA</a>: decreased</li>
  • -</ul>
  • -</li>
  • -<li>
  • -<strong>DWI</strong><ul><li>almost all restrict diffusion</li></ul>
  • -</li>
  • -</ul><p>Leptomeningeal seeding has been described in up to 15-30% of cases and so post-contrast imaging of the entire neuroaxis should be considered in suspected AT/RTs.</p><h4>Treatment and prognosis</h4><p>Surgery with debulking can be offered in some cases. Tumours can demonstrate leptomeningeal dissemination. Clinically AT/RTs have a much poorer prognosis than medulloblastomas, with little if any response to chemotherapy and death usually occurring within a year of diagnosis. </p><h4>History and etymology</h4><p>Primary CNS rhabdoid tumour was first identified as a unique entity in the mid/late 1980s. Prior to this, these tumours were likely misdiagnosed as primitive neuroectodermal tumour/<a href="/articles/medulloblastoma">medulloblastoma</a>, as they are relatively similar in microscopic appearance <sup>12</sup>. Early reports variably used the term <strong>malignant rhabdoid tumour</strong>.</p><h4>Differential diagnosis</h4><p>Imaging differential considerations include:</p><ul>
  • -<li>
  • -<a title="Embryonal tumour with multilayered rosettes" href="/articles/embryonal-tumour-with-multilayered-rosettes">embryonal tumour with multilayered rosettes</a> particularly for supratentorial AT/RTs</li>
  • -<li>
  • -<a href="/articles/medulloblastoma">medulloblastoma</a><ul>
  • -<li>tends to occur in an older age group <sup>6</sup>
  • -</li>
  • -<li>rarely involve cerebellopontine angle</li>
  • -<li>haemorrhage is much less frequently seen than in AT/RTs <sup>6</sup>
  • -</li>
  • -</ul>
  • -</li>
  • -<li><a href="/articles/intracranial-teratoma">intracranial teratoma</a></li>
  • +<p><strong>Atypical teratoid/rhabdoid tumours</strong> <strong>(AT/RT)</strong> are uncommon <a href="/articles/who-classification-of-cns-tumours-1">WHO grade 4</a> tumours, which in the vast majority of cases occurs in young children less than two years of age. It most frequently presents as a <a href="/articles/posterior-fossa-tumours">posterior fossa mass</a>. AT/RT often resembles <a href="/articles/medulloblastoma">medulloblastoma</a> by imaging and even H&amp;E microscopy, and the diagnosis requires cytogenetic analysis of the tissue.</p><h4>Epidemiology</h4><p>AT/RTs typically present in very young children (median age is less than 2-3 years <sup>2,13</sup>).</p><h4>Pathology</h4><h5>Microscopic features</h5><p>Rhabdoid cells are the hallmark of AT/RT, but only comprise a fraction of the tumour and are not required for the diagnosis provided genetic of DNA-methylation changes are compatible (see below) <sup>13</sup>.</p><p>Other portions of the tumour are indistinguishable on imaging and histology from a medulloblastoma or <a href="/articles/embryonal-tumour-with-multilayered-rosettes">embryonal tumour with multilayered rosettes</a>.</p><h5>Genetics</h5><p>The vast majority (~95%) of AT/RTs have inactivation of both copies of SMARCB1 (also known as INI1, BAF47 or hSNF5). In a small minority of cases (&lt; 5%) it is SMARCA4 (also known as BRG1) that is inactivated <sup>13</sup>. </p><p>Additionally, AT/RTs can be divided into three subgroups according to <a href="/articles/dna-methylation">DNA-methylation profiling</a>: AT/RT-SHH, AT/RT-TYR, and AT/RT-MYC <sup>13</sup>.</p><p>To make the diagnosis, either SMARCB1 or SMARCA4 mutations or compatible DNA-methylation profiling need to identified <sup>13</sup>. </p><h5>Immunophenotype</h5><p>Rhabdoid cells usually demonstrate:</p><ul>
  • +<li>
  • +<a href="/articles/epithelial-membrane-antigen-ema">EMA</a>: positive</li>
  • +<li>
  • +<a href="/articles/vimentin">vimentin</a>: positive</li>
  • +<li>
  • +<a href="/articles/smooth-muscle-actin">SMA</a> (smooth muscle actin): positive</li>
  • +</ul><h4>Radiographic features</h4><p>Atypical teratoid/rhabdoid tumours are usually large and very heterogeneous masses. They may be difficult to distinguish from an embryonal tumour with multilayered rosettes by imaging.</p><h5>Location</h5><ul>
  • +<li>infratentorial: ~50%<ul>
  • +<li>cerebellum (most common)</li>
  • +<li>brainstem</li>
  • +</ul>
  • +</li>
  • +<li>supratentorial<ul>
  • +<li>cerebral hemispheres</li>
  • +<li>pineal gland region (see <a href="/articles/pineal-region-mass">pineal mass differential diagnosis</a>)</li>
  • +<li>septum pellucidum</li>
  • +<li>hypothalamus</li>
  • +</ul>
  • +</li>
  • +</ul><h5>CT</h5><ul>
  • +<li>often isodense to grey matter</li>
  • +<li>may demonstrate heterogeneous enhancement</li>
  • +<li>calcification is common</li>
  • +<li>may show associated <a href="/articles/obstructive-hydrocephalus">obstructive hydrocephalus</a>
  • +</li>
  • +</ul><h5>MRI</h5><p>Can show necrosis, multiple foci of cyst formation and sometimes haemorrhage:</p><ul>
  • +<li>
  • +<strong>T1:</strong> iso- to slightly hyperintense to grey matter (haemorrhagic areas can be more hyperintense)</li>
  • +<li>
  • +<strong>T2:</strong> generally hyperintense (haemorrhagic areas can be hypointense)</li>
  • +<li>
  • +<strong>T1 C+ (Gd):</strong> heterogeneous enhancement</li>
  • +<li>
  • +<strong>MR spectroscopy</strong><ul>
  • +<li>
  • +<a href="/articles/choline-peak">Cho</a>: elevated</li>
  • +<li>
  • +<a href="/articles/n-acetylaspartate-naa-peak">NAA</a>: decreased</li>
  • +</ul>
  • +</li>
  • +<li>
  • +<strong>DWI</strong><ul><li>almost all restrict diffusion</li></ul>
  • +</li>
  • +</ul><p>Leptomeningeal seeding has been described in up to 15-30% of cases and so post-contrast imaging of the entire neuroaxis should be considered in suspected AT/RTs.</p><h4>Treatment and prognosis</h4><p>Surgery with debulking can be offered in some cases. Tumours can demonstrate leptomeningeal dissemination. Clinically AT/RTs have a much poorer prognosis than medulloblastomas, with little if any response to chemotherapy and death usually occurring within a year of diagnosis. </p><h4>History and etymology</h4><p>Primary CNS rhabdoid tumour was first identified as a unique entity in the mid/late 1980s. Prior to this, these tumours were likely misdiagnosed as primitive neuroectodermal tumour/<a href="/articles/medulloblastoma">medulloblastoma</a>, as they are relatively similar in microscopic appearance <sup>12</sup>. Early reports variably used the term <strong>malignant rhabdoid tumour</strong>.</p><h4>Differential diagnosis</h4><p>Imaging differential considerations include:</p><ul>
  • +<li>
  • +<a title="Embryonal tumour with multilayered rosettes" href="/articles/embryonal-tumour-with-multilayered-rosettes">embryonal tumour with multilayered rosettes</a> particularly for supratentorial AT/RTs</li>
  • +<li>
  • +<a href="/articles/medulloblastoma">medulloblastoma</a><ul>
  • +<li>tends to occur in an older age group <sup>6</sup>
  • +</li>
  • +<li>rarely involve cerebellopontine angle</li>
  • +<li>haemorrhage is much less frequently seen than in AT/RTs <sup>6</sup>
  • +</li>
  • +</ul>
  • +</li>
  • +<li><a href="/articles/intracranial-teratoma">intracranial teratoma</a></li>

References changed:

  • 2. Meyers S, Khademian Z, Biegel J, Chuang S, Korones D, Zimmerman R. Primary Intracranial Atypical Teratoid/Rhabdoid Tumors of Infancy and Childhood: MRI Features and Patient Outcomes. AJNR Am J Neuroradiol. 2006;27(5):962-71. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975730">PMC7975730</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/16687525">Pubmed</a>
  • 2. Meyers SP, Khademian ZP, Biegel JA et-al. Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes. AJNR Am J Neuroradiol. 2006;27 (5): 962-71. <a href="http://www.ajnr.org/cgi/content/full/27/5/962">AJNR Am J Neuroradiol (full text)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/16687525">Pubmed citation</a><div class="ref_v2"></div>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.